Some receptors show consistent associations across cancers; for example, ADORA2A is invariably associated to higher survival across four distinct cancer tissues (including pancreas, breast, skin, and head and neck; Figure 4B), which might be consistent with its known role in regulating CD8+ T cell activity and survival in the TME.28 Here, ADORA2A is linked to cancer.